Skip to main content

A discussion by Safir Anand on the laws and codes of practices governing advertising of medicinal products in India.

In India, pharmaceutical advertising is governed by The Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 and The Drugs and Cosmetics Rules, 1945. However these Acts do not lay down the minimum essential information requirements for advertisements. The Organization of Pharmaceutical Producers of India in its Code of Pharmaceutical Marketing Practices also provide guidelines for the information requirements in advertisements and the allowed practices for the promotion of pharmaceutical products. The Indian department of Pharmaceuticals has also come up with a Code of Marketing Practice for Indian Pharmaceutical Industry which is a voluntary code of Marketing Practices for Indian Pharmaceutical Industry.

This chapter was published in ICLG’s Pharmaceutical Advertising 2013.

To continue reading, please contact us at email@anandandanand.com

Most Recent

News & Insights

VIEW ALL
News & Updates
Sep 12, 2025

Aishwarya Rai Bachchan personality rights case: As Delhi HC grants interim protection to the Actor, Mr Pravin Anand spoke exclusively to ANI (Asian News

Aishwarya Rai personality case: Pravin Anand’s exclusive with ANI
News & Updates
Sep 12, 2025

Team Anand and Naik recently represented Mr. Abhishek Bachchan before the Delhi High Court, helping him secure his personality and publicity rights. Hon’ble

Team Anand and Naik Secures Personality Rights Protection for Mr. Abhishek Bachchan
News & Updates
Sep 11, 2025

Team Anand and Naik recently represented Mrs. Aishwarya Rai Bachchan before the Delhi High Court, helping her secure protection of her Personality and

Team Anand and Naik Secures Personality Rights Protection for Mrs. Aishwarya Rai Bachchan
News & Updates
Aug 25, 2025

At the FICCI–ICRIER Conference on SEPs (23rd August 2025), our Managing Partner Mr. Pravin Anand shared his vision on how India can evolve from being

Conference on Standard Essential Patents (SEPs)